Northeast
Ohio
Chapter
Anna and Her Mom
Northeast Ohio
Research
Top Research Highlight - Winter 2012
Interested in research news? Check out our winter edition of Top Research Highlights. In this issue, you will read about:
- a study that found that normal bacteria living in the intestines—called gut microbes—may influence the development of autoimmune disorders, including T1D
- a JDRF-funded study that used pancreases donated to the Network for Pancreatic Organ Donors with Diabetes to determine that that people at risk of developing T1D have smaller pancreases and fewer insulin-producing beta cells…
Top Research Highlights - Spring 2012
Learn more about our research progress by from our most recent issue of Top Research Highlights. In the issue, you will read about:
- Exciting news from JDRF-funded research at Oregon Health & Science University and Legacy Health, where researchers have developed a stable liquid formulation of glucagon, a key component in the development of bihormonal diabetes pumps and next-generation artificial pancreas systems
- Positive results from two JDRF-funded outpatient clinical trials of artificial pancreas systems
- Insight…
2012 Research Summit
The goal of JDRF research is 1) to CURE T1D 2) develop better ways to TREAT T1D and 3) to PREVENT T1D from occurring. To that end JDRF has awarded more than $1.6 billion to diabetes research since its founding in 1970. Past JDRF efforts have helped to significantly advance the care of people with this disease, and have expanded the critical scientific understanding of T1D. In May 2012 JDRF hosted a Research Summit in…
JDRF Research Overview
JDRF is the leading charitable funder and advocate of type 1 (juvenile) diabetes research worldwide. JDRF has established a set of cure therapeutics to guide its research funding efforts. These research goal areas hold the greatest potential to lead to breakthrough cures and treatments for type 1 diabetes and its complications:
If you would like more information about JDRF research, watch the videos of our 2011 Annual Meeting guest speaker, Senior Vice President of…
Type 1 Diabetes Investigators —Aided by JDRF Research Project—Are First to Identify “Killer” T Cells within Human Islets
A team of researchers recently became the first to catch “killer” cells at the scene of the crime—the pancreas—where they bring about the autoimmune attack that is a hallmark of type 1 diabetes (T1D). The researchers used human tissue samples from T1D organ donors obtained through nPOD, a JDRF collaborative research project.
Investigators at the La Jolla Institute of Allergy and Immunology in San Diego, CA, used actual human pancreatic tissue from donors with…
JDRF Research Report - Dec 2011
Here is the latest research progress report on the exciting research being funded by JDRF.
JDRF_Research_Report_Dec_2011.pdf
JDRF Encouraged By Draft FDA Artificial Pancreas Guidance
FDA’s Draft Guidance Is A First Step to Providing Access to Life-Saving Technology for Millions with Type 1 Diabetes
Washington, D.C. – The JDRF today said it is encouraged that the Food and Drug Administration (FDA) has issued a draft guidance which appears to lay a foundation for accelerating the development and availability of artificial pancreas technology (AP) that will improve the lives of millions of Americans living with type 1 diabetes (T1D).…
Northeast Ohio Chapter Annual Meeting
The Northeast Ohio Chapter of JDRF - 2011 Annual Meeting and Research Update
Guest Speaker - Research Update
This event took place on Thursday, June 16, 2011 with guest speaker Darlene C. Deecher, Ph.D, Senior Vice President, Research.
Darlene C. Deecher, Ph.D., oversees all aspects of the JDRF research department including grants administration operations. You can read her full bio on the JDRF Senior Staff page.
Here…
Cool Research News
JDRF is working hard to find better treatments and a cure for both kids and adults with type 1 diabetes - from people who were diagnosed last week, to people who were diagnosed decades ago. We’re funding lots of research projects to find different methods that might work.
Here are some samples of the many efforts underway right now to cure, treat and prevent type 1 diabetes:
Artificial Pancreas…Top Research Highlights Summer 2010
The JDRF portfolio of diabetes research is among the largest in the world focused on cures and better treatments for type 1 diabetes and its complications. With funding of nearly $101 million in FY2009, representing research in more than 20 countries and including numerous human clinical trials, JDRF science is aimed at moving research discoveries into products, drugs, and treatments for people with diabetes. The major findings and developments JDRF funded over the past year,…
JDRF Research Collaboration with Pfizer, Hadassah, and The Hebrew University
JDRF Announces Diabetes Research Collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem
NEW YORK, March 22, 2010 - The Juvenile Diabetes Research Foundation, a leader in setting the agenda for diabetes research worldwide, said today that it will begin a diabetes research collaboration with Pfizer, Hadassah Medical Organization, and The Hebrew University of Jerusalem on drugs to replicate and regenerate insulin-producing cells in people with type 1 diabetes.The…
JDRF in Partnership with Animas
JDRF in Groundbreaking Partnership with Animas to Develop First-Generation Artificial Pancreas System
The development of an artificial pancreas—a fully automated system to dispense insulin to people with diabetes based on real-time changes in blood sugar levels—
would be among the most revolutionary advancements in treating type 1 diabetes. Today, JDRF took the first steps on that path, with the groundbreaking announcement
of an innovative partnership with Animas Corporation, a Johnson & Johnson company…JDRF and BD Collaborate to Improve Insulin Pump Delivery
R&D Program Targets Opportunities to Improve Glucose Control and Help People with Diabetes Lead Healthier Lives
New York, NY and Franklin Lakes, NJ (January 19, 2010) - The Juvenile Diabetes Research Foundation (JDRF) and BD (Becton, Dickinson and Company) (NYSE:BDX) announced today an innovative program aimed at improving the treatment of type 1 diabetes by developing novel insulin delivery products to enhance the use of insulin pumps.
Through the program, JDRF will support BD’s…
Resources 
Archives
- May, 2013
- April, 2013
- March, 2013
- February, 2013
- December, 2012
- October, 2012
- August, 2012
- June, 2012
- May, 2012
- April, 2012
- March, 2012
- January, 2012
- December, 2011
- November, 2011
- September, 2011
- August, 2011
- July, 2011
- June, 2011
- May, 2011
- April, 2011
- March, 2011
- February, 2011
- January, 2011
- November, 2010
Donations Needed!
» Donate Now
Twitter 
- Did you know that JDRF hosts an annual golf outing? This year, each of our golfers will receive a new pair of... http://t.co/Ing69tXYFI
- Are you looking for an internship? JDRFNEO has two internship positions available. We are looking for a... http://t.co/calG3tiePj
» Follow @JDRFneo
